Keywords: coulter, sb, suffer, bexxar, resubmission, pharmaceuticals, smithkline

Coulter and SB suffer on Bexxar resubmission

Article | 31 August 1999

Coulter Pharmaceuticals and SmithKline Beecham have been asked toprovide the US Food and Drug Administration with additional analyses of Bexxar ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Bexxar

Tositumomab and Iodine 1131 Tositumomab

Ibritumomab Tiuxetan

Zevalin

Rituxan

Go to drug listing